Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma. [electronic resource]
Producer: 20140114Description: 175-6 p. digitalISSN:- 1365-2710
- Aged
- Carcinoma, Renal Cell -- drug therapy
- Humans
- Immunosuppressive Agents -- adverse effects
- Indazoles
- Kidney Neoplasms -- drug therapy
- Male
- Posterior Leukoencephalopathy Syndrome -- chemically induced
- Pyrimidines -- adverse effects
- Sulfonamides -- adverse effects
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.